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Abstract
The spatial organization of the genome is essential for the precise control of gene expression. Recent advances in sequencing
and imaging technologies allow us to explore the 3D genome and its relationship to gene regulation at an unprecedented
scale. In this review, we provide an overview of lessons learned from studying the chromatin structure and their implications
in communications between gene promoters and distal cis-regulatory elements, such as enhancers. We first review the
current knowledge of general genome organization, followed by the importance of chromatin folding in gene regulation.
Next, we proceed to a brief survey of the recently developed chromosome conformation capture technologies, as well as most
widely adopted read-outs from such data. We then introduce two emerging models that offer explanations regarding how
distal enhancers achieve transcriptional control of target genes in the 3D genome. Last, we discuss the promising prospects
of leveraging knowledge in chromatin spatial organization for studying complex diseases and traits.
General Features of Genome Structure
To fit the entire genome of 2-m-long human DNA sequences,
containing 3 billion nucleotides, in the nucleus of a diameter
of 10 mm, DNA has to be packed and organized achieving 105
compaction. In vitro structure study of the chromatin showed
that every 146 bp of DNA is wrapped around nucleosome (11 nm
diameter), providing 5–6 compaction. At the next level,
nucleosomes are compacted into the 30 nm chromatin fiber,
achieving an additional 50 compaction (1). The chromatin is
thought to be further compacted into fibers sized several nano-
meters. However, this hierarchical model of chromosome com-
paction was challenged by new findings of chromatin structure
in nucleus using ChromEMT (2). Unlike in vitro, chromatin is a
disorganized chain with diameter 5–24 nm in situ. Chromatin
chains are flexible and compacted in different densities with
various particle arrangements and conformations (2). Such ob-
servation suggests that chromatin fibers are organized at differ-
ent local chromatin concentrations instead of being folded in a
hierarchical order. It remains elusive how precisely such
observed chromatin polymer structure determines DNA acces-
sibilities and gene regulation. We learned chromosomes are
organized in chromosome territories as the basic structure of
genome organization by cell biology studies (3) (Fig. 1A).
Chromosome territories are arranged in a somewhat non-
random fashion so that small, gene-rich chromosomes tend to
locate at the center of the nucleus (4). More recently, molecular
approaches with chromatin conformation assays have revealed
many insights regarding chromatin structure at different reso-
lutions. For example, the first survey of genome-wide chroma-
tin interaction, at 1 Mb resolution, showed that the genome is
partitioned into compartments ‘A’ and ‘B’. ‘A’ is the open and
actively transcribed regions and ‘B’ the compacted and re-
pressed regions of the genome (5) (Fig. 1B). Later, several studies
were conducted in an attempt to gain a better understanding of
spatial organization of genomes by increasing data resolution
with in-depth sequencing (6,7). Collective results from these
studies demonstrated that the genome is partitioned into Mb-
sized topologically associated domains (TADs) containing
coregulated genes and cis-regulatory elements (6,8). Disruption
of CTCF occupied TAD boundary leads to rearrangement of
promoter–enhancer looping and abnormal expression of limb
developmental genes (9), for example. Within TADs, chromatin
forms loops between enhancer and promoter sequences
(Fig. 1C). Such regulatory chromatin loops are cell type-specific,
serving as the driving force to determine the cellular identity
and linking to many disease-associated variants (10–14). These
studies provide a general understanding of the higher-order
structure of the genome for coordinated gene regulation and
highlight the importance of studying 3D genome structure in
cell type-specific transcriptional regulation.
One Primary Motivation: the Mechanism by
which Enhancers Achieve Gene Regulation
Enhancers regulate transcription by recruiting transcriptional
factors and coactivators that facilitate gene transcription
(15,16). For instance, pioneer factors such as FOXA1 are known
to initiate chromatin remodeling, leading to histone modifica-
tions (e.g. H3K4 methylation) at enhancer sequences in a tissue-
specific manner (17). Tissue-specific transcription factors then
bind to enhancers in response to signaling, and further recruit-
ing transcriptional machinery to target genes via chromatin
looping. Enhancer–promoter (E–P) loops are mediated by CTCF,
cohesion and mediator (18). A number of excellent reviews dis-
cuss recent research on transcriptional network and chromatin
remodeling related to enhancers (19–21).
Large international efforts including ENCODE (22) and
Roadmap Epigenomics (23) projects have mainly focused on map-
ping tissue-specific enhancers via chromatin states and accessi-
bilities. These efforts provide one-dimensional (1D) annotation
and have identified hundreds of thousands of putative cis-regula-
tory elements in the mammalian genome. More recently, the 4D
Nucleome Consortium (24) has been assembled with the goal to
understand the general principals of spatial and temporal chro-
matin organization and the roles of chromatin loops in gene reg-
ulation and cell function. Enhancers can regulate target genes
from distal (25,26), and in some cases, even Mb away (27). Such
long-range regulation, combined with high abundance of en-
hancer elements compared to the promoter sequences in the
mammalian genome, renders a dauntingly large number of po-
tential physical interactions, making systematically mapping E–P
communications challenging. Because of that, single nulceotide
polymorphisms (SNPs) associated with diseases or traits from the
genome-wide association studies (GWAS) were conveniently
assigned to the nearest gene within certain linear DNA distance
(nearest gene model). However, this model has been challenged
by examples of SNPs regulating genes further away instead of the
closet one(s). For example, FTO intronic variants regulating IRX3
in the brain (28), and IRX3 and IRX5 in adipocytes (29), respec-
tively; an ARL15 intronic variant regulating FST (26); and several
others (13,30–32), indicating the complexity and cell type specific-
ity for the functions of regulatory variants.
C-technologies to Study Genome-Wide
Chromatin Interactions
It is generally accepted that enhancer and the promoter of its
target gene should be brought to close physical proximity medi-
ated by transcription factors and cofactors. Many techniques
have been developed to investigate chromatin organization in
the nucleus. Chromosome conformation capture (3C) (33), the
original C-technology to study one-to-one interactions (i.e. be-
tween two pre-defined DNA segments), has successfully identi-
fied many E–P interactions including the human beta and alpha
globin loci (34,35). Later, 3C derivative methods including 4C
(36), 5C (37), Hi-C (5), Chromatin Interaction Analysis by Paired-
End Tag Sequencing (38), promoter capture Hi-C (39), HiChIP (40)
and Proximity Ligation-Assisted ChIP-seq (41), have been subse-
quently developed for interrogation of chromatin interactions
at different scales and resolutions. The comparison of these dif-
ferent techniques is nicely described in many excellent recent
reviews (11,19,20,42).
Common Read-Outs of Genome-Wide
Chromatin Structure Data
With Hi-C approach, an ever-increasing deluge of 3D chromatin
data has been generated. Efficiently analyzing these data is
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Figure 1. Schematic diagram of genome organization and gene regulation. Chromosomes are organized into territories in the mammalian genome (A), A/B compart-
ments (transcriptional active versus repressive domains), and TADs (physical constrain of enhancer-promoter interactions) (B). TADs boundaries are insulated by
CTCF/cohesin complex (C). Within TADs, enhancer and promoter form chromatin loops with super-enhancers and their target genes tend to have better phase separa-
tion (depicted in dark grey) due to the higher concentration of local TFs and transcriptional machinery than typical enhancers (depicted in light grey) (C).
imperative but, as an understatement, non-trivial (19,20). Hi-C
data typically contain 0.1–5 billion raw reads per sample, with
various biases and noises. Quality control is therefore challeng-
ing, usually involving multi-layer pre-processing (6,7,9,10,12,43–
47) and normalization (7,12,48–50) before analysis, as well as
reproducibility checks during and after analysis (51,52). Excellent
reviews exist (19,20,53) for readers interested in statistical
and bioinformatics analysis details. Major read-outs from
such genome-wide chromatin structure data include multi-Mb
resolution ‘A’ (open and actively transcribed) and ‘B’ (compacted
and repressed) compartments, Mb resolution topologically
associating domains (TADs), tens-kb resolution Frequently
Interacting REgions (FIREs) (12) and high (e.g. kb) resolution chro-
matin loops and interactions (Fig. 1).
Models for Regulatory Chromatin Interactions
Between Promoters and Enhancers
Model 1: enhancer–promoter (E–P) interactions are
restricted by the spatial partition of the genome
One possible model for E–P interactions suggested by recent stud-
ies of chromatin spatial organization is that TADs, discrete Mb-
sized chromatin territories, serve to restrict long-range interac-
tions between enhancers and promoters. TADs are found to be
relatively stable over many cell divisions, between different cell
types and evolutionarily conserved (6,54). Increasing evidences
support the functional roles of TADs, including gene regulation
within TAD, DNA replication timing control and propagation of
chromatin state along the DNA. For example, genes within the
same TAD tend to have coordinated expression dynamics during
differentiation, suggesting TAD’s role in concerting the activities
of neighboring genes (6,8,54,55). Studies on expression and his-
tone quantitative trait loci (eQTL and hQTL) indicate that co-
regulation of regulatory elements tend to occur within the same
TAD (56,57). Dynamic and cell type-specific chromatin loops be-
tween enhancers and promoter usually occur within TAD (7,58)
and mediated by CTCF, cohesion complex and mediator complex
(18,59). Disruption of TAD boundaries can lead to ectopic activa-
tion of enhancers across the boundaries, subsequently to abnor-
mal gene expression and eventually to noticeable phenotypes or
diseases (9,20,44,60). For example, developmental disorders, such
as syndactyly and congenital limb malformations, and some pe-
diatric brain disorders, have recently been found to be caused by
the disruption of TAD boundaries and consequent dysregulation
of disease-causing genes (9,44,60). At domain boundaries, chro-
matin loops are formed by loop extrusion (61–63). Specifically, a
pair of cohesion complexes binds to form a loop extrusion factor,
slides along the genome and stops upon contact of domain
boundary factors, such as a pair of convergent oriented CTCF
motifs, forming an extruded chromatin loop. Such CTCF and co-
hesion complexes are hallmarks of TAD boundaries (6,59) (Fig. 1B
and C). Disrupting CTCF binding or inverting the direction of
CTCF motif can lead to aberrant loop formation, and subse-
quently transcriptional dysregulation. For example, copy number
variations overlapping CTCF motif are found to result in enhancer
hijacking, which plays a significant role in aberrant gene activa-
tion for many types of cancer (60,64,65).
Model 2: phase separation model for enhancer–
promoter communication
The second model, phase separation, suggests that cooperative
binding (of transcription factors, cofactors and RNA polymerase to
enhancer and promoter sequences) leads to a high local density
of protein and nucleotide concentration. Such high concentration
of multi-molecular assemblies can form a gel-like phase-sepa-
rated compartment for transcription (66–68). Phase separation is
considered to play essential roles in the formation of heterochro-
matin and super-enhancers, both of high molecular density de-
spite the dramatic difference in functional activities. Such high-
density multi-molecule complex fosters separation and creation
of relatively self-contained entities, facilitating compartmentali-
zation of biochemical reactions such as transcription (Fig. 1C).
Therefore, it is proposed that phase separation occurs more fre-
quently at super-enhancers than at typical enhancers. The phase
separation model provides an explanation for the formation of su-
per-enhancers and their sensitivity to various perturbations; the
functional mechanisms for enhancers simultaneously regulating
multiple genes; how multiple typical enhancers orchestrate gene
activation and transcription bursting (67).
The models reviewed above offer insights into enhancers
and promoter communication to achieve cell type-specific gene
regulation. These two models are not mutually exclusive:
enhancers and promoters can be organized and connected by
cell type-specific transcription factors which lead to condensa-
tion and phase separation within TADs with boundaries stabi-
lized by loop extrusion.
Future perspectives for genetic dissection of human
diseases and traits
To date, many GWAS studies have been conducted and identified
over >50 000 SNPs significantly associated with various human
diseases and traits (69). However, the vast majority of these
GWAS SNPs reside in regulatory regions with mostly elusive un-
derlying mechanisms, preventing further leveraging the results
for clinical applications. Recently mapped cis-regulatory elements
have already started to deliver on the promise of aiding interpre-
tation of GWAS results and generating mechanistic hypotheses
at GWAS loci. For example, several recent multi-tissue/cell type
studies of chromatin structure (10,12–14) have demonstrated that
tissue-specific E–P contacts are essential for elucidating the roles
of non-coding variants in disease development.
Cell type-specific cataloging of functional elements is critical
for the identification of causal regulatory SNPs and for revealing
the underlying biological mechanisms. Compared to the large
number of GWAS SNPs identified, functional characterization of
GWAS SNPs remains challenging for a number of reasons: first,
many regulatory SNPs function in a cell type-specific manner,
yet there is still a significant lack of comprehensive annotation
of regulatory sequences in physiologically relevant cell types.
Second, GWAS variants mostly exert moderate or small effects
on phenotypic traits such that their effects are susceptible to
confounding or dilution by genetic background and noisy read-
outs in validation experiments. Third, functional validations of
each genetic variant have been mainly tested individually while
the functional regulatory region can easily encompass multiple
genetic variants working synergistically. For example, in a re-
cent study of Hirschsprung disease (70), three SNPs were shown
to be associated with three independent enhancers, all regulat-
ing the same targeting gene RET. Further investigation revealed
that these three enhancers were synergistic such that carrying
all three risk alleles results in a much higher risk of developing
the disease. Lastly, cis-regulatory elements often interact with
their cognate genes over long genomic distances, precluding a
straightforward, systematic mapping of promoter and enhancer
connectivity. Consequently, our ability to interpret and derive
mechanistic insights from GWAS results remains limited.
Uncovering chromatin spatial organizations at various reso-
lutions across many tissues and conditions will continue to aid
prioritization of critical regulatory regions, in cell type-, disease-
and condition-specific manners. Examples of the target genes of
GWAS SNPs not being the nearest gene include the well-known
obesity-associated FTO intronic variants actually regulating
IXR3 gene 490 kb away in brain (28), schizophrenia-associated
variant regulating FOXG1 gene 764 kb away in radial glia cells
(13) and an ARL15 intronic variant most likely controlling FST
gene 522 kb away in liver (26,30). The prioritized variants
based on 1D regulatory element annotation can be further eval-
uated with a combination of functional characterization assays
including CRISPR-Cas9 mediated genome editing (71,72), mas-
sively parallel reporter assay (MPRA) (73) and imaging technolo-
gies such as Fluorescent in situ hybridization. For example,
when evaluating a GWAS locus (typically with multiple SNPs
identified to be associated with phenotypic trait of interest), be-
sides leveraging tissue-specific 1D epigenomic annotations to
identify potential regulatory elements, additional evaluation of
SNP(s) based on 3D interactions can help prioritize which one(s)
for functional follow-up. Integrating GWAS results with 1D and
3D information, we can then examine the most promising
SNP(s) to assess whether the alternative alleles result in dis-
rupted E–P interactions. In the future, integrative approaches
combining chromatin spatial organization studies with GWAS
studies, along with other multi-omic data, will facilitate reveal-
ing genetic mechanisms underlying complex human diseases
and traits, ultimately leading to the development of effective
preventive method, diagnosis and drug treatment of these
diseases.
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